Lords Mark Industries Ltd Issues 10.28 Lakh Shares to BCCL at ₹158

Lords Mark Industries Ltd has submitted a Regulation 30 update regarding its ongoing legal matter with Bennett Coleman and Company Limited (BCCL). In continuation of a previous disclosure, the company has issued 10,28,483 equity shares to BCCL at a conversion price of ₹158 per share, as per the Share Cum Warrant Subscription Agreement dated August 1, 2023. This development is significant as BCCL, a major media institution, sought to convert its entitlement at this valuation. Lords Mark Industries Limited has honored this commitment, viewing it as an indicator of confidence in the company's long-term strategy and growth potential. The company is now initiating the process for listing and trading approval for these shares on BSE Limited. Lords Mark Industries has a diversified presence across healthcare, diagnostics, MedTech, dialysis, renewable energy, and advanced medical technologies.